Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03057665 · ClinicalTrials.gov registry record
Atomic Magnetometer for Fetal Biomagnetism
A clinical trial, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- 43
- Enrollment target
NCT03057665: Completed study, sponsored by University of Wisconsin, Madison.
NCT03057665 is a clinical trial that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 43 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03057665 has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- 43 participants
- Enrollment target
Study Summary
The goal of this study is the evaluation of an atomic magnetometer that is practical for human biomagnetism studies. The investigators have built a device that has the necessary sensitivity, and will be testing it on a small number of adults and approximately 30 healthy pregnant subjects, in preparation for beginning pre-clinical studies of high-risk pregnancies.
Primary Outcome
Measure single-to-noise for acquisition of fetal magnetocardiograms
Interventions
- DEVICE Atomic Biomagnetometer
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2010-10 |
| Est. Completion | 2019-04-01 |
What the finished NCT03057665 record still lists
NCT03057665 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 43 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Atomic Biomagnetometer is the first listed.
NCT03057665 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03057665 about?
NCT03057665 is a clinical study titled "Atomic Magnetometer for Fetal Biomagnetism". The goal of this study is the evaluation of an atomic magnetometer that is practical for human biomagnetism studies. The investigators have built a device that has the necessary sensitivity, and will be testing it on a small number of adults and approximately 30 healthy pregnant subjects, in prepara...
What is the current status of trial NCT03057665?
This trial is currently completed. The enrollment target is 43 participants. The study started on 2010-10. Estimated completion is 2019-04-01.
What interventions are being tested in trial NCT03057665?
The interventions under investigation include: Atomic Biomagnetometer (DEVICE).
Who is sponsoring clinical trial NCT03057665?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03726359 · 43 participants · Phase 1
Phase I Study of Fractionated Stereotactic Radiation Therapy
- NCT03850418 · 43 participants · Phase 2
Azacitidine and Chimerism in MDS or AML Patients After Allogeneic Stem Cell Transplant
- NCT04144023 · 43 participants · Phase 1
A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ
- NCT04176718 · 43 participants · Phase 2
Daratumumab, Carfilzomib, Pomalidomide, Dexamethasone In MM
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia